Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jesse D. Ortendahl, Amanda L. Harmon, Tanya G. K. Bentley & Michael S. Broder. (2017) A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies. Journal of Medical Economics 20:7, pages 767-775.
Read now
Read now
Tom Brett, Gerald F Watts, Diane E Arnold-Reed, Damon A Bell, Jacquie Garton-Smith, Alistair W Vickery, Jacqueline DM Ryan & Jing Pang. (2015) Challenges in the care of familial hypercholesterolemia: a community care perspective. Expert Review of Cardiovascular Therapy 13:10, pages 1091-1100.
Read now
Read now
Nkechinyere Ijioma & Jennifer G Robinson. (2011) Lipid-lowering effects of ezetimibe and simvastatin in combination. Expert Review of Cardiovascular Therapy 9:2, pages 131-145.
Read now
Read now
Steve E Humphries & H Andrew W Neil. (2010) Developing and applying clinically useful approaches to identify individuals with familial hypercholesterolemia in the UK. Clinical Lipidology 5:4, pages 497-507.
Read now
Read now
Stella S. Daskalopoulou, Robert J. Doonan & Dimitri P. Mikhailidis. (2010) Undertreatment of hypercholesterolemia. Current Medical Research and Opinion 26:2, pages 439-443.
Read now
Read now
Articles from other publishers (32)
Nadeem Qureshi, Bethan Woods, Rita Neves de Faria, Pedro Saramago Goncalves, Edward Cox, Jo Leonardi-Bee, Laura Condon, Stephen Weng, Ralph K Akyea, Barbara Iyen, Paul Roderick, Steve E Humphries, William Rowlands, Melanie Watson, Kate Haralambos, Ryan Kenny, Dev Datta, Zosia Miedzybrodzka, Christopher Byrne & Joe Kai. (2023) Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technology Assessment, pages 1-140.
Crossref
Crossref
Luiz Sérgio Fernandes de Carvalho, Andrea Dias Stephanus & Mariana Savedra Pfitzner. (2023) When economy meets physiopathology: A novel cost-effectiveness model finally considers the cumulative effect of LDL cholesterol burden. Atherosclerosis 367, pages 34-36.
Crossref
Crossref
Rita Faria, Pedro Saramago, Edward Cox, Stephen Weng, Barbara Iyen, Ralph K. Akyea, Steve E. Humphries, Nadeem Qureshi & Beth Woods. (2023) How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis. Atherosclerosis 367, pages 40-47.
Crossref
Crossref
Maria Cristina de Oliveira Izar, Viviane Zorzanelli Rocha Giraldez, Adriana Bertolami, Raul Dias dos SantosFilhoFilho, Ana Maria Lottenberg, Marcelo Heitor Vieira Assad, José Francisco Kerr Saraiva, Ana Paula M. Chacra, Tania L. R. Martinez, Luciana Ribeiro Bahia, Francisco Antonio Helfenstein Fonseca, Andre Arpad Faludi, Andrei C. Sposito, Antônio Carlos Palandri Chagas, Cinthia Elim Jannes, Cristiane Kovacs Amaral, Daniel Branco de Araújo, Dennys Esper Cintra, Elaine dos Reis Coutinho, Fernando Cesena, Hermes Toros Xavier, Isabela Cardoso Pimentel Mota, Isabela de Carlos Back Giuliano, José Rocha FariaNetoNeto, Juliana Tieko Kato, Marcelo Chiara Bertolami, Marcio Hiroshi Miname, Maria Helane Costa Gurgel Castelo, Maria Sílvia Ferrari Lavrador, Roberta Marcondes Machado, Patrícia Guedes de Souza, Renato Jorge Alves, Valeria Arruda Machado & Wilson SalgadoFilhoFilho. (2021) Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021. Arquivos Brasileiros de Cardiologia.
Crossref
Crossref
Oleg V. Fatenkov, Yana A. Panisheva, Mariya A. Galkina & Il'nar Kh. Sytdykov. (2019) PHARMACOECONOMICS OF TREATMENT PATIENTS WITH HIGH LEVEL HYPERCHOLESTEROLEMIA. Science and Innovations in Medicine 4:1, pages 26-31.
Crossref
Crossref
Tom Brett, Nadeem Qureshi, Samuel Gidding & Gerald F. Watts. (2018) Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part. Atherosclerosis 277, pages 399-406.
Crossref
Crossref
Aleksandra Pelczarska, Michał Jakubczyk, Joanna Jakubiak-Lasocka, Maciej Banach, Małgorzata Myśliwiec, Marcin Gruchała & Maciej Niewada. (2018) The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland. Atherosclerosis 270, pages 132-138.
Crossref
Crossref
Ching-Yun Wei, Ruben G. W. Quek, Guillermo Villa, Shravanthi R. Gandra, Carol A. Forbes, Steve Ryder, Nigel Armstrong, Sohan Deshpande, Steven Duffy, Jos Kleijnen & Peter Lindgren. (2016) A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies. PharmacoEconomics 35:3, pages 297-318.
Crossref
Crossref
Livio Garattini & Anna Padula. (2017) Cholesterol-lowering drugs: science and marketing. Journal of the Royal Society of Medicine 110:2, pages 57-64.
Crossref
Crossref
Lee A. Pyles, Eloise Elliott & William A. Neal. (2017) Screening for Hypercholesterolemia in Children: What Strategies Can Be Employed. Current Cardiovascular Risk Reports 11:2.
Crossref
Crossref
V V Simerzin, O V Fatenkov, I V Gagloeva, M A Galkina, Ya A Panisheva & I Kh Sytdykov. (2016) INNOVATIVE TECHNOLOGIES IN DIAGNOSIS AND TREATMENT OF EXTREME FAMILIAL HYPERCHOLESTEROLEMIA. Science and Innovations in Medicine 1:4, pages 23-30.
Crossref
Crossref
Shravanthi R. Gandra, Guillermo Villa, Gregg C. Fonarow, Mickael Lothgren, Peter Lindgren, Ransi Somaratne & Ben van Hout. (2016)
Cost‐Effectiveness of
LDL
‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
. Clinical Cardiology 39:6, pages 313-320.
Crossref
Crossref
Nadeem Qureshi, Stephen Weng, Jennifer Tranter, Alia El-Kadiki & Joe Kai. (2016) Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study. BMJ Open 6:5, pages e011734.
Crossref
Crossref
Karen Broekhuizen, Marieke F van Wier, Lando L J Koppes, Johannes Brug, Willem van Mechelen, Judith E Bosmans & Mireille N M van Poppel. (2015) An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with Familial Hypercholesterolemia. BMC Research Notes 8:1.
Crossref
Crossref
Yuichi J. Shimada & Christopher P. Cannon. (2015) PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future. European Heart Journal 36:36, pages 2415-2424.
Crossref
Crossref
Albert Wiegman, Samuel S. Gidding, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Marina Cuchel, Leiv Ose, Maurizio Averna, Catherine Boileau, Jan Borén, Eric Bruckert, Alberico L. Catapano, Joep C. Defesche, Olivier S. Descamps, Robert A. Hegele, G. Kees Hovingh, Steve E. Humphries, Petri T. Kovanen, Jan Albert Kuivenhoven, Luis Masana, Børge G. Nordestgaard, Päivi Pajukanta, Klaus G. Parhofer, Frederick J. Raal, Kausik K. Ray, Raul D. Santos, Anton F.H. Stalenhoef, Elisabeth Steinhagen- Thiessen, Erik S. Stroes, Marja-Riitta Taskinen, Anne Tybjærg-Hansen & Olov Wiklund. (2015) Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. European Heart Journal 36:36, pages 2425-2437.
Crossref
Crossref
Caroline S. Bennette, Carlos J. Gallego, Wylie Burke, Gail P. Jarvik & David L. Veenstra. (2014) The cost-effectiveness of returning incidental findings from next-generation genomic sequencing. Genetics in Medicine 17:7, pages 587-595.
Crossref
Crossref
D.R. Sullivan, G.F. Watts, S.J. Nicholls, P. Barter, R. Grenfell, C.K. Chow, A. Tonkin & A. Keech. (2015) Clinical Guidelines on Hyperlipidaemia: Recent Developments, Future Challenges and the Need for an Australian Review. Heart, Lung and Circulation 24:5, pages 495-502.
Crossref
Crossref
D. R. Sullivan, L. Freeman, L. Molloy & G. Williams. (2015) Screening for Familial Hypercholesterolaemia: Universal or Cascade? A Critique of Current FH Recognition Strategies. Current Cardiovascular Risk Reports 9:2.
Crossref
Crossref
Zanfina Ademi, Gerald F. Watts, Jing Pang, Eric J.G. Sijbrands, Frank M. van Bockxmeer, Peter O'Leary, Elizabeth Geelhoed & Danny Liew. (2014) Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia. Journal of Clinical Lipidology 8:4, pages 390-400.
Crossref
Crossref
Gerald F. Watts, Samuel Gidding, Anthony S. Wierzbicki, Peter P. Toth, Rodrigo Alonso, W. Virgil Brown, Eric Bruckert, Joep Defesche, Khoo Kah Lin, Michael Livingston, Pedro Mata, Klaus G. Parhofer, Frederick J. Raal, Raul D. Santos, Eric J.G. Sijbrands, William G. Simpson, David R. Sullivan, Andrey V. Susekov, Brian Tomlinson, Albert Wiegman, Shizuya Yamashita & John J.P. Kastelein. (2014) Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. Journal of Clinical Lipidology 8:2, pages 148-172.
Crossref
Crossref
Gerald F. Watts, Samuel Gidding, Anthony S. Wierzbicki, Peter P. Toth, Rodrigo Alonso, W. Virgil Brown, Eric Bruckert, Joep Defesche, Khoo Kah Lin, Michael Livingston, Pedro Mata, Klaus G. Parhofer, Frederick J. Raal, Raul D. Santos, Eric J.G. Sijbrands, William G. Simpson, David R. Sullivan, Andrey V. Susekov, Brian Tomlinson, Albert Wiegman, Shizuya Yamashita & John J.P. Kastelein. (2014) Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. International Journal of Cardiology 171:3, pages 309-325.
Crossref
Crossref
B. G. Nordestgaard, M. J. Chapman, S. E. Humphries, H. N. Ginsberg, L. Masana, O. S. Descamps, O. Wiklund, R. A. Hegele, F. J. Raal, J. C. Defesche, A. Wiegman, R. D. Santos, G. F. Watts, K. G. Parhofer, G. K. Hovingh, P. T. Kovanen, C. Boileau, M. Averna, J. Boren, E. Bruckert, A. L. Catapano, J. A. Kuivenhoven, P. Pajukanta, K. Ray, A. F. H. Stalenhoef, E. Stroes, M.-R. Taskinen & A. Tybjaerg-Hansen. (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. European Heart Journal 34:45, pages 3478-3490.
Crossref
Crossref
Zanfina Ademi, Gerald F. Watts, Amanda Juniper & Danny Liew. (2013) A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia. International Journal of Cardiology 167:6, pages 2391-2396.
Crossref
Crossref
Damon A. Bell, Robert Bender, Amanda J. Hooper, Jenny McMahon, Glenn Edwards, Frank M. van Bockxmeer, Gerald F. Watts & John R. Burnett. (2013) Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia. Clinica Chimica Acta 422, pages 21-25.
Crossref
Crossref
Philippa J Talmud, Sonia Shah, Ros Whittall, Marta Futema, Philip Howard, Jackie A Cooper, Seamus C Harrison, KaWah Li, Fotios Drenos, Frederik Karpe, H Andrew W Neil, Olivier S Descamps, Claudia Langenberg, Nicholas Lench, Mika Kivimaki, John Whittaker, Aroon D Hingorani, Meena Kumari & Steve E Humphries. (2013) Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. The Lancet 381:9874, pages 1293-1301.
Crossref
Crossref
Brian W. McCrindle, Peter O. Kwiterovich, Patrick E. McBride, Stephen R. Daniels & Rae-Ellen W. Kavey. (2012) Guidelines for Lipid Screening in Children and Adolescents: Bringing Evidence to the Debate. Pediatrics 130:2, pages 353-356.
Crossref
Crossref
Roberta Ara, Hasan Basarir & Sue Elizabeth Ward. (2012) Principles of health economic evaluations of lipid-lowering strategies. Current Opinion in Lipidology 23:4, pages 271-281.
Crossref
Crossref
Dov Shiffman, Katherine Slawsky, Lauren Fusfeld, James J. Devlin & Thomas F. Goss. (2012) Cost-Effectiveness Model of Use of Genetic Testing as an Aid in Assessing the Likely Benefit of Aspirin Therapy for Primary Prevention of Cardiovascular Disease. Clinical Therapeutics 34:6, pages 1387-1394.
Crossref
Crossref
Robert Bender, Damon A. Bell, Amanda J. Hooper, Glenn Edwards, Frank M. van Bockxmeer, Gerald F. Watts & John R. Burnett. (2012) Screening for familial hypercholesterolaemia. Pathology 44:2, pages 122-128.
Crossref
Crossref
Gerald F. Watts, David R Sullivan, Nicola Poplawski, Frank van Bockxmeer, Ian Hamilton-Craig, Peter M. Clifton, Richard O’Brien, Warrick Bishop, Peter George, Phillip J. Barter, Timothy Bates, John R. Burnett, John Coakley, Patricia Davidson, Jon Emery, Andrew Martin, Waleed Farid, Lucinda Freeman, Elizabeth Geelhoed, Amanda Juniper, Alexa Kidd, Karam Kostner, Ines Krass, Michael Livingston, Suzy Maxwell, Peter O’Leary, Amal Owaimrin, Trevor G. Redgrave, Nicola Reid, Lynda Southwell, Graeme Suthers, Andrew Tonkin, Simon Towler & Ronald Trent. (2011) Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements 12:2, pages 221-263.
Crossref
Crossref
Steve E Humphries. (2011) Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): Are we coming to a consensus?. Atherosclerosis Supplements 12:2, pages 217-220.
Crossref
Crossref